441 related articles for article (PubMed ID: 31172218)
1. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
Muri L; Leppert D; Grandgirard D; Leib SL
Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and ADAMs in stroke.
Montaner J; Ramiro L; Simats A; Hernández-Guillamon M; Delgado P; Bustamante A; Rosell A
Cell Mol Life Sci; 2019 Aug; 76(16):3117-3140. PubMed ID: 31165904
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
Leppert D; Lindberg RL; Kappos L; Leib SL
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles of metalloproteinases in neurological disorders.
Yang Y; Hill JW; Rosenberg GA
Prog Mol Biol Transl Sci; 2011; 99():241-63. PubMed ID: 21238938
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in the CNS: interferons get nervous.
Chopra S; Overall CM; Dufour A
Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
Gasche Y; Soccal PM; Kanemitsu M; Copin JC
Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
[TBL] [Abstract][Full Text] [Related]
9. Implication of matrix metalloproteinases in regulating neuronal disorder.
Mukherjee A; Swarnakar S
Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in neuroinflammation.
Rosenberg GA
Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
[TBL] [Abstract][Full Text] [Related]
11. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
Rosenberg GA
Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
[TBL] [Abstract][Full Text] [Related]
13. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Candelario-Jalil E; Yang Y; Rosenberg GA
Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
[TBL] [Abstract][Full Text] [Related]
14. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
Lindberg RL; De Groot CJ; Montagne L; Freitag P; van der Valk P; Kappos L; Leppert D
Brain; 2001 Sep; 124(Pt 9):1743-53. PubMed ID: 11522577
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy.
Opdenakker G; Abu El-Asrar A
Cell Mol Life Sci; 2019 Aug; 76(16):3157-3166. PubMed ID: 31183508
[TBL] [Abstract][Full Text] [Related]
16. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z
Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and their inhibitors in neurological disease.
Lopez-Navarro ER; Gutierrez J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):27-38. PubMed ID: 34851449
[TBL] [Abstract][Full Text] [Related]
18. MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.
Li Y; Wang W; Li L; Khalil RA
Life Sci; 2020 Jul; 253():117659. PubMed ID: 32283055
[TBL] [Abstract][Full Text] [Related]
19. Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream.
Okazaki I; Nabeshima K
Anticancer Agents Med Chem; 2012 Sep; 12(7):688-706. PubMed ID: 22292751
[TBL] [Abstract][Full Text] [Related]
20. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
Sharma D; Singh NK
Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
